What is Aspen Aerogels's impairment of assets held for sale?

Aspen Aerogels (ASPN) reported impairment of assets held for sale of $3.61M in Q4 2025.

How has Aspen Aerogels's impairment of assets held for sale changed year-over-year?

Aspen Aerogels's impairment of assets held for sale increased by 349.2% year-over-year, from $803K to $3.61M.

Aspen Aerogels ASPN Impairment of assets held for sale

Impairment of assets held for sale at other companies

AlbemarleALB

——

Honeywell InternationalHON

——

Other financials

Income statement

See full

Revenue$37.9M-51.9%

Gross profit$4.3M-81.3%

Operating income-$20.8M+93.0%

Net income-$23.7M+92.1%

EPS (diluted)-$0.29+92.1%

Balance sheet

See full

Cash & equivalents$173.9M-9.5%

Total debt$113.4M-18.8%

Total equity$213.5M-32.2%

Total assets$410.5M-26.0%

Cash flow

See full

Operating cash flow$34.1M+506%

CapEx$1.4M-89.5%

Free cash flow$32.8M+545%

Valuation

See full

Market cap$470.74M-1.1%

Enterprise value$410.28M-3.1%

P/S2×+1.0×

Profitability

See full

Gross margin32.9%-7.1pp

Operating margin-43.3%-8.2pp

Net margin-48.6%-9.9pp

FCF margin-22.3%-10.1pp

Returns & leverage

See full

Return on equity-42.4%-12.2pp

Debt / equity0.5×+0.1×

Current ratio2.9×-1.3×

Where this comes from

Reported directly by Aspen Aerogels in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf.

The official record: Aspen Aerogels’s 10-K/A, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aspen Aerogels's impairment of assets held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aspen Aerogels's impairment of assets held for sale?: Aspen Aerogels (ASPN) reported impairment of assets held for sale of $3.61M in Q4 2025.
How has Aspen Aerogels's impairment of assets held for sale changed year-over-year?: Aspen Aerogels's impairment of assets held for sale increased by 349.2% year-over-year, from $803K to $3.61M.